TCK-276
- Generic Name
- TCK-276
A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis
- First Posted Date
- 2022-06-29
- Last Posted Date
- 2024-10-11
- Lead Sponsor
- Teijin America, Inc.
- Target Recruit Count
- 32
- Registration Number
- NCT05437419
- Locations
- 🇺🇸
San Marcus Research Clinic, Inc., Miami Lakes, Florida, United States
🇺🇸Allied Biomedical Research Institute, Miami, Florida, United States
🇺🇸Floridian Clinical Research, LLC, Miami Lakes, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath